A primigravida at 41 weeks gestation is admitted for labor induction due to post-term pregnancy. The cervix is 1 cm dilated, 50% effaced, and the fetal head is at -2 station. Which nursing intervention should be the priority before beginning oxytocin administration?

With an unfavorable cervix (Bishop score 4), cervical ripening is prioritized before oxytocin to improve induction success and reduce cesarean risk. Other options are interventions for later stages or after cervical ripening.

Understanding the Clinical Scenario
The question presents a primigravida at 41 weeks gestation with an unfavorable cervix: dilated only 1 cm, 50% effaced, and the fetal head at a high -2 station. The core task is to identify the priority nursing intervention before initiating oxytocin administration. This requires an understanding of the physiological prerequisites for successful labor induction.

Why Cervical Ripening is the Priority
The cervix must be "ripe" or favorable for oxytocin to effectively stimulate coordinated uterine contractions that lead to dilation and effacement. A cervix that is only 1 cm dilated and 50% effaced is considered unripe. Administering oxytocin in the presence of an unripe cervix is associated with a higher risk of failed induction, which can lead to prolonged labor, increased maternal exhaustion, and a greater likelihood of cesarean delivery. The systematic review and meta-analysis by Okobi et al. (2026) confirms that the comparative effectiveness of induction methods is critically influenced by cervical status ^[1]. The evidence supports a sequential approach: cervical ripening first to prime the cervix, followed by oxytocin to drive active labor. This is the foundational rationale for prioritizing a ripening agent.

Analysis of Incorrect Options
The other options represent interventions that are either premature, inappropriate for the given cervical status, or not the immediate priority.
- Option 1 (Insert an intrauterine pressure catheter): An intrauterine pressure catheter (IUPC) is used to quantitatively measure the strength, frequency, and resting tone of contractions. It is an invasive monitoring tool typically reserved for situations where external tocodynamometry is inadequate or when precise measurement is clinically necessary, such as in a labor dystocia evaluation. It is not a prerequisite for starting oxytocin and does not address the primary problem of an unripe cervix.
- Option 3 (Rupture membranes artificially): Artificial rupture of membranes (amniotomy) is a method of labor augmentation or induction, but it is generally not recommended as a primary intervention when the cervix is unfavorable and the fetal head is high at -2 station. Performing an amniotomy with a high presenting part significantly increases the risk of umbilical cord prolapse, an obstetric emergency. Cervical ripening should precede this step to allow the fetal head to descend and engage against the cervix.
- Option 4 (Begin oxytocin infusion at the lowest recommended dose): While initiating oxytocin at the lowest dose is a standard safety practice, the priority is to first optimize the cervical environment for the drug to be effective. Starting oxytocin with an unripe cervix is a common cause of induction failure, as the uterus contracts against a rigid, closed cervix, which can lead to fetal distress without meaningful labor progress.

Synthesizing the Evidence for Cervical Ripening
The provided research underscores the importance of mechanical and pharmacological cervical ripening as a distinct and critical phase of labor induction. The meta-analysis by Zhou et al. (2026) specifically examines techniques for inserting a Foley catheter, a widely used mechanical method for cervical ripening, highlighting its role in preparing the unfavorable cervix . Furthermore, the study by Izakson et al. (2026) compares another mechanical method, the double-balloon catheter, directly for the purpose of cervical ripening, reinforcing that this is a standard, evidence-based step before proceeding to agents that stimulate contractions . Even the investigation of novel pharmacological agents like tafoxiparin by Ekman-Ordeberg et al. (2026) is focused on the specific clinical problem of an "unripe cervix" in nulliparous women scheduled for induction, demonstrating that cervical status is the pivotal factor guiding initial management . The collective evidence firmly establishes that for a primigravida with an unripe cervix, the priority nursing intervention is to facilitate cervical ripening before administering oxytocin.